Bacteria in gene therapy: bactofection versus alternative gene therapy (Q36257622)

13 August 2017

1 reference

title

Bacteria in gene therapy: bactofection versus alternative gene therapy (English)

1 reference

13 August 2017

0 references

Pálffy R

1

1 reference

13 August 2017

Gardlík R

2

1 reference

13 August 2017

Hodosy J

3

1 reference

13 August 2017

Behuliak M

4

1 reference

13 August 2017

Resko P

5

1 reference

13 August 2017

Radvánský J

6

1 reference

13 August 2017

Celec P

7

1 reference

13 August 2017

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

13

1 reference

13 August 2017

2

1 reference

13 August 2017

101-105

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302635

13 August 2017

0 references

cites work

Gene therapy: the first decade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Innovations in oral gene delivery: challenges and potentials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Bacteria-mediated DNA transfer in gene therapy and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Direct transfer of cloned genes from bacteria to mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Modulation of the immune system by Listeria monocytogenes-mediated gene transfer into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor--an alternative gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Recombinant Escherichia coli as a gene delivery vector into airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Functional gene transfer from intracellular bacteria to mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Bacteria as gene delivery vectors for mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Use of preferentially replicating bacteria for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Microorganisms and Cancer: Quest for a Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Clostridia in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Listeria monocytogenes mediated CFTR transgene transfer to mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Oral somatic transgene vaccination using attenuated S. typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Specific interference by ingested dsRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Gene delivery systems--gene therapy vectors for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302635

21 January 2018

Identifiers

DOI

10.1038/SJ.GT.3302635

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference